Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2001
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of flavopiridol in treating patients who have unresectable or metastatic kidney cancer.
Epistemonikos ID: f71cb86baeefd07c4889cc03fe3df397fe77c529
First added on: May 03, 2024